rs13158763
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001102562.3(MARCHF11):c.694-2440C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.299 in 151,714 control chromosomes in the GnomAD database, including 7,907 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.30 ( 7907 hom., cov: 31)
Consequence
MARCHF11
NM_001102562.3 intron
NM_001102562.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.314
Publications
2 publications found
Genes affected
MARCHF11 (HGNC:33609): (membrane associated ring-CH-type finger 11) MARCH11 is a member of the MARCH family of membrane-bound E3 ubiquitin ligases (EC 6.3.2.19). These enzymes add ubiquitin (see MIM 191339) to target lysines in substrate proteins, thereby signaling their intracellular transport. March11 appears to have a role in ubiquitin-mediated protein sorting in the trans-Golgi network (TGN)-multivesicular body (MVB) transport pathway (Morokuma et al., 2007 [PubMed 17604280]).[supplied by OMIM, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.547 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MARCHF11 | ENST00000332432.9 | c.694-2440C>T | intron_variant | Intron 2 of 3 | 5 | NM_001102562.3 | ENSP00000333181.7 | |||
| MARCHF11 | ENST00000507111.1 | c.103-25728C>T | intron_variant | Intron 1 of 1 | 3 | ENSP00000424425.1 | ||||
| MARCHF11 | ENST00000505509.1 | n.275-2440C>T | intron_variant | Intron 2 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.299 AC: 45311AN: 151596Hom.: 7896 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
45311
AN:
151596
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.299 AC: 45348AN: 151714Hom.: 7907 Cov.: 31 AF XY: 0.312 AC XY: 23153AN XY: 74094 show subpopulations
GnomAD4 genome
AF:
AC:
45348
AN:
151714
Hom.:
Cov.:
31
AF XY:
AC XY:
23153
AN XY:
74094
show subpopulations
African (AFR)
AF:
AC:
6988
AN:
41372
American (AMR)
AF:
AC:
6734
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
AC:
754
AN:
3458
East Asian (EAS)
AF:
AC:
2876
AN:
5096
South Asian (SAS)
AF:
AC:
2413
AN:
4794
European-Finnish (FIN)
AF:
AC:
4998
AN:
10496
Middle Eastern (MID)
AF:
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
AC:
19607
AN:
67928
Other (OTH)
AF:
AC:
632
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1489
2978
4468
5957
7446
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
462
924
1386
1848
2310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1623
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.